STOK
Stoke Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$33.19
-3.29 ▼ -9.02%
🌙 3월 13일 7:26 PM ET (한국 3/14 08:26)
$33.17
-0.02 ▼ -0.06%
| Index | RUT | P/E | 50.3 | EPS (ttm) | 0.66 | Insider Own | 22.07% | Shs Outstand | 0.06B | Perf Week | -6.45% |
| Market Cap | 1.90B | Forward P/E | - | EPS next Y | -2661.9% | Insider Trans | -2.12% | Shs Float | 0.04B | Perf Month | 3.01% |
| Enterprise Value | 1.65B | PEG | - | EPS next Q | -0.74 | Inst Own | 109.27% | Short Float | 27.86% | Perf Quarter | -2.81% |
| Income | 0.04B | P/S | 9.22 | EPS this Y | 107.42% | Inst Trans | 11.56% | Short Ratio | 16.69 | Perf Half Y | 38.99% |
| Sales | 0.21B | P/B | 5.94 | EPS next 5Y | -19.01% | ROA | 12.41% | Short Interest | 12.40M | Perf YTD | 4.57% |
| Book/sh | 5.59 | P/C | 7.63 | EPS past 3/5Y | 10.98% 1.74% | ROE | 15.02% | 52W High | -17.48% ($40.22) | Perf Year | 309.25% |
| Cash/sh | 4.35 | P/FCF | 36.2 | Sales past 3/5Y | - | ROIC | 13.09% | 52W Low | 520.37% ($5.35) | Perf 3Y | 247.9% |
| Dividend Est. | - | EV/EBITDA | 52.57 | EPS Y/Y TTM | 133.83% | Gross Margin | 97.94% | Volatility(W/M) | 7.51% 6.97% | Perf 5Y | -35.25% |
| Dividend TTM | - | EV/Sales | 8.03 | Sales Y/Y TTM | 1128.17% | Oper. Margin | 13.23% | ATR (14) | 2.5 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 6.53 | EPS Q/Q | -39.48% | Profit Margin | 19.73% | RSI (14) | 45.29 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.53 | Sales Q/Q | 117.25% | SMA20 | -5.32% ($35.05) | Beta | 1.18 | Target Price | $41.7 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 11000000 | SMA50 | 1.35% ($32.75) | Rel Volume | 2.45 | Prev Close | $36.48 |
| Employees | 128 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | -14.4% 72.6% | SMA200 | 35.96% ($24.41) | Avg Volume(3M) | 0.74M | Price | $33.19 |
| IPO | 2019/6/19 | Option/Short | Yes/Yes | Trades | 12362 | Volume | 1,821,244 | Change | -9.02% |
뉴스 로딩 중...